Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?

Women whose pregnancies are at judged to be at risk of a poor outcome from an early delivery due to medical problems such as diabetes or high blood pressure, are often very anxious during pregnancy, at least until they know they have passed the risk period of premature birth (after 8 months). Anxiety itself can have a significant effect on the developing baby, on the newborn child and the mother-infant bonding process. We will use a combination of pregnancy blood tests and an ultrasound assessment to check on placental function, since placental damage is the greatest cause of poor outcome. Most women tested this way will have normal results, and so may feel reassured and do better in pregnancy than untested women. The benefits may extend after birth to mother-infant bonding, breastfeeding success and a reduced risk of postnatal depression. We will randomly select an equal number of women for testing and no testing (like tossing a coin, known as a randomized control trial) to be confident that any benefits observed are genuine. The potential benefits of our research would be substantial for the mental health of many pregnant women, for their newborn and for their children as they grow up. The tests are easy to do and would add very little in terms of a woman's and in terms of the total costs of prenatal care.

Study Overview

• Status: Unknown
• Conditions: High-Risk Pregnancy
• Intervention / Treatment: Other: placental function assessment

Detailed Description

Women whose pregnancies are considered "high-risk" for medical reasons such (e.g. preeclampsia, coagulation problems), often develop anxiety because of the possibility of a poor outcome. Such anxiety can affect fetal development, neonatal wellbeing, child development and maternal mental health but it often goes unrecognized. Also, women are often reluctant to use medications during pregnancy, especially if they perceive there may be the slightest risk to the fetus. By assessing placental function at mid-pregnancy in this population, we can provide an accurate estimate of which women will develop severe complications later in the pregnancy. We propose to perform a pilot randomized control trial formally incorporating placental assessment (Doppler ultrasound of the uterine artery and reassessment of diagnostic tests done earlier in pregnancy), with one group of "high-risk" women receiving the intervention (followed by feedback). Measures of pregnancy outcome and anxiety will be compared with a control group receiving standard "high-risk" pregnancy care. Levels of anxiety will be measured throughout the pregnancy using standardized scales. We hypothesize that placental function testing will reduce the burden of anxiety for the majority of women who test negative in the placental assessment arm and that these women will have improved outcomes and measures of anxiety during and following pregnancy in comparison with untested women who perceive themselves to be at risk of pregnancy complications throughout pregnancy. We also anticipate that the outcome of the pregnancy in women in the "tested" group will be more favorable (e.g. reduced admissions of neonate to NICU).

• Study Type: Interventional
• Enrollment (Anticipated): 160
• Phase: Phase 1

Contacts and Locations

• Study Contact: Name: Eileen P. Sloan, MD; Phone Number: 8693 416-586-4800; Email: esloan@mtsinai.on.ca
• Study Contact Backup: Name: Barbara Field; Phone Number: 8325 416-586-4800; Email: bfield@mtsinai.on.ca

Study Locations

• Canada
  • Ontario
    • Toronto, Ontario, Canada, M5G 1X5
      • Mount Sinai Hospital
      • Principal Investigator: Eileen P. Sloan, MD
      • Sub-Investigator: Cynthia Maxwell, MD
      • Sub-Investigator: William J. Lancee, Ph.D.
      • Sub-Investigator: John C. Kingdom, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Patient of maternal/fetal medicine unit Mount Sinai Hospital
• Over 18 years of age
• Able to understand the nature of the study
• Able to provide consent to participation
• Singleton pregnancy
• Normal karyotype
• No major anatomical malformations at the 19 week ultrasound
• Fluent in English

Exclusion Criteria:

• Currently suffering from a major psychiatric illness or current use of psychotropic medications
• Current illegal substance or alcohol abuse
• Presence of a significant fetal structural abnormality on the 19 week ultrasound
• Abnormal karyotype
• Multifetal pregnancy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Active group; Receive assessment of placental function	Other: placental function assessment; Formal assessment of placental function in mid-gestation by placental morphology and uterine artery Doppler at 20-22 weeks and re-interpretation of prior biochemical tests for Down's syndrome and spina bifida.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Primary outcome measure is STAI - The State Trait Anxiety Inventory	Cross-sectional

Secondary Outcome Measures

Outcome Measure	Time Frame
Women who undergo the placental function assessment will deliver at a later gestation age, have less complications and stillbirths than untested women. Neonates will have higher APGAR scores at 1 and 5 minutes and less likely to be admitted to the NICU.	Cross-sectional

Collaborators and Investigators

• Sponsor: Mount Sinai Hospital, Canada
• Collaborators: Ontario Mental Health Foundation
• Investigators: Principal Investigator: Eileen P. Sloan, MD, Mount Sinai Hospital, Canada

Study record dates

Study Registration Dates

• First Submitted: October 16, 2007
• First Submitted That Met QC Criteria: October 17, 2007
• First Posted (Estimate): October 18, 2007

Study Record Updates

• Last Update Posted (Estimate): October 18, 2007
• Last Update Submitted That Met QC Criteria: October 17, 2007
• Last Verified: October 1, 2007

More Information

Terms related to this study

• Keywords: psychological distress; placental function; high-risk pregnancies
• Other Study ID Numbers: Sloan01